Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shuanghuang Yangxue Decoction
- Development stage
- Preclinical
- Lead developer
- Yueyang Hospital of Integrated Traditional Chinese and Western Medicine
- Administration
- Oral
01
Overview
Shuanghuang Yangxue Decoction is a Traditional Chinese Medicine (TCM) herbal formula developed for the treatment of cancer-related anemia, specifically in patients with lung cancer and iron deficiency. It is being evaluated in clinical trials sponsored by the Yueyang Hospital of Integrated Traditional Chinese and Western Medicine. The decoction is formulated based on TCM principles to nourish blood and tonify qi, aiming to improve hematological parameters such as hemoglobin levels and serum ferritin. As a decoction, it is prepared by boiling a specific combination of herbs and is administered orally.
- Other names
- Shuanghuang Yangxue Tang
Beyond the preview
Go deeper on Shuanghuang Yangxue Decoction.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shuanghuang Yangxue Decoction.